Paushak Q2 FY27 Results: Board Meet on 16 Oct 2026

Key update from the exchange filing

Paushak Limited has informed BSE and NSE that its Board of Directors will meet on Friday, 16 October 2026. The stated agenda is to consider and approve the company’s unaudited financial results for the quarter and half year ended 30 September 2026. The company’s filing does not disclose any financial figures or expected outcome from the meeting. For investors, the meeting date effectively anchors the near-term results calendar for the stock.

What the board will consider on 16 October

The board meeting is intended to review the unaudited numbers for the September 2026 quarter (Q2 FY27) as well as the half-year period. Such results typically provide an early view of trends in revenue and profit before audited annual statements are published. The exchange communication also indicates that other agenda items may be taken up, though the filing highlighted the financial results as the primary item. Any management commentary, if released alongside results, will likely come through subsequent regulatory filings.

Trading window: closure and reopening timeline

Paushak’s exchange communication notes a compliance step around insider trading norms. The filing states that the securities trading window will reopen 48 hours after the results are declared. Separately, the provided disclosure also states that the trading window will close on 1 October 2026 and remain shut until 48 hours after the unaudited Q2 results are declared. This matters for market participants because it signals when designated persons are restricted from trading and when normal trading permissions resume after the price-sensitive announcement.

Results calendar: what is known so far

The corporate actions and results calendar shared in the note lists two recent result events for Paushak. Q1 FY27 results were reported on 30 July 2026, and Q2 FY27 results are scheduled for 16 October 2026. These dates help investors track how quickly the company reports through the year and when the next material update is expected.

The latest disclosed performance: Q1 FY27 snapshot

The most recent financial performance cited in the provided text is for Q1 FY27. Paushak Limited reported a 25.5% year-on-year rise in net profit to ₹15.10 crore (₹151.0 million). Revenue rose 49.5% year-on-year to ₹83.55 crore (₹835.5 million). These figures set the context going into the September quarter results, especially because Q2 numbers will indicate whether the pace seen in Q1 carried forward.

Corporate actions investors track alongside results

Apart from earnings, the note also flags earlier corporate actions that can influence how investors view shareholder returns and capital structure. Paushak has declared a 50% dividend with an ex-date of 23 July 2026. The company has also announced a 5:10 stock split with an ex-date of 3 October 2025, and a 3:1 bonus issue with the same ex-date of 3 October 2025. While these actions are not directly tied to the October 2026 meeting agenda, they remain part of the company’s recent corporate timeline.

Why this board meeting matters for the stock

The company’s unaudited quarterly and half-yearly results are among the most price-sensitive disclosures in a reporting cycle. The provided text explicitly notes that these results give investors an early view of revenue, profit trends and cash-flow before the audited annual statements. It also notes that any material deviation from market expectations can affect sentiment and the stock’s short-term price movement. Since the filing itself does not provide figures, the key immediate takeaway is the timing and the compliance-related trading window schedule.

What to watch after the meeting

The next concrete item for investors is the result announcement that typically follows the board meeting. Market participants will also monitor any management commentary released through filings, along with any follow-up documents such as financial statements and related disclosures. The provided FAQ section also points investors to where quarterly earnings results and presentations are generally made available, namely the Annual Reports and Financial Documents section under the company’s Resources tab.

Market impact: what is confirmed, and what is not

What is confirmed is the event schedule: the board meeting on 16 October 2026, the consideration of unaudited results for the quarter and half year ended 30 September 2026, and the trading window reopening 48 hours after results are declared. What is not confirmed in the filing is any specific financial outcome, guidance, or forecast. As a result, any market reaction ahead of the meeting would be driven by anticipation of the announcement date rather than disclosed performance indicators for Q2.

Conclusion

Paushak’s regulatory filing sets 16 October 2026 as the key date for approving unaudited Q2 FY27 and half-year results ended 30 September 2026. The same set of disclosures highlights trading window restrictions until 48 hours after the results are declared. The next definitive update for investors will be the results disclosure and any related exchange filings released around the board meeting.